Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Operating Expenses: 2017-2025

Historic Operating Expenses for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to $130.1 million.

  • Organogenesis Holdings' Operating Expenses rose 19.46% to $130.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $334.1 million, marking a year-over-year decrease of 18.77%. This contributed to the annual value of $367.6 million for FY2024, which is 17.02% up from last year.
  • As of Q3 2025, Organogenesis Holdings' Operating Expenses stood at $130.1 million, which was up 14.58% from $113.6 million recorded in Q2 2025.
  • Organogenesis Holdings' 5-year Operating Expenses high stood at $144.1 million for Q2 2024, and its period low was $696,000 during Q4 2024.
  • In the last 3 years, Organogenesis Holdings' Operating Expenses had a median value of $85.1 million in 2024 and averaged $89.7 million.
  • Data for Organogenesis Holdings' Operating Expenses shows a peak YoY increase of 77.37% (in 2024) and a maximum YoY decrease of 99.05% (in 2024) over the last 5 years.
  • Quarterly analysis of 5 years shows Organogenesis Holdings' Operating Expenses stood at $75.5 million in 2021, then increased by 5.53% to $79.7 million in 2022, then decreased by 8.20% to $73.2 million in 2023, then slumped by 99.05% to $696,000 in 2024, then grew by 19.46% to $130.1 million in 2025.
  • Its Operating Expenses was $130.1 million in Q3 2025, compared to $113.6 million in Q2 2025 and $89.7 million in Q1 2025.